The FDA announced that the shortage of tirzepatide, the active ingredient in Eli Lilly’s weight loss drug Zepbound, is resolved, ending the ability of compounding pharmacies...
Nike’s turnaround under new CEO Elliott Hill will take longer than anticipated, following a decline in revenue and profit attributed to deep discounting. Hill plans to...
Jason Wilk, CEO of fintech company Dave, faced a significant crisis in June 2023 when the company’s stock plummeted below $5, reducing its value from $5...
As college sports programs generate billions in revenue annually, private investors are increasingly interested in their valuations. CNBC has ranked the 75 most valuable NCAA Football...
Freehold Raceway, America’s oldest horse racetrack, will close after 170 years due to declining attendance and failed attempts to secure a casino. However, there is optimism...
Esther Gonzalez of Spain celebrated her team’s FIFA Women’s World Cup victory by kissing the trophy on August 20, 2023. In a significant move, Netflix announced...
Starbucks baristas are planning strikes through Christmas Eve in cities like Los Angeles, Chicago, and Seattle, as part of an effort led by Starbucks Workers United...
The Consumer Financial Protection Bureau (CFPB), led by Rohit Chopra, has sued the operator of Zelle and its banking partners—JPMorgan Chase, Bank of America, and Wells...
Party City announced the closure of all its stores and immediate corporate layoffs due to ongoing financial struggles. CEO Barry Litwin informed employees that Friday marked...
Eli Lilly’s Zepbound injection pen has been approved by the FDA as the first drug treatment for patients with obesity and moderate-to-severe obstructive sleep apnea (OSA)....